150 related articles for article (PubMed ID: 17631855)
1. A continuous assay for foot-and-mouth disease virus 3C protease activity.
Jaulent AM; Fahy AS; Knox SR; Birtley JR; Roqué-Rosell N; Curry S; Leatherbarrow RJ
Anal Biochem; 2007 Sep; 368(2):130-7. PubMed ID: 17631855
[TBL] [Abstract][Full Text] [Related]
2. A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates.
Wang QM; Johnson RB; Cox GA; Villarreal EC; Loncharich RJ
Anal Biochem; 1997 Oct; 252(2):238-45. PubMed ID: 9344409
[TBL] [Abstract][Full Text] [Related]
3. A continuous fluorimetric assay for tail-specific protease.
Beebe KD; Pei D
Anal Biochem; 1998 Oct; 263(1):51-6. PubMed ID: 9750142
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
[TBL] [Abstract][Full Text] [Related]
5. A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitors.
Schünemann K; Connelly S; Kowalczyk R; Sperry J; Wilson IA; Fraser JD; Brimble MA
Bioorg Med Chem Lett; 2012 Aug; 22(15):5018-24. PubMed ID: 22763202
[TBL] [Abstract][Full Text] [Related]
6. NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison.
Bjorndahl TC; Andrew LC; Semenchenko V; Wishart DS
Biochemistry; 2007 Nov; 46(45):12945-58. PubMed ID: 17944485
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding.
Vincents B; von Pawel-Rammingen U; Björck L; Abrahamson M
Biochemistry; 2004 Dec; 43(49):15540-9. PubMed ID: 15581366
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of foot-and-mouth disease virus 3C protease: a viable target for antiviral drugs?
Curry S; Roqué-Rosell N; Sweeney TR; Zunszain PA; Leatherbarrow RJ
Biochem Soc Trans; 2007 Jun; 35(Pt 3):594-8. PubMed ID: 17511659
[TBL] [Abstract][Full Text] [Related]
9. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates.
Taliani M; Bianchi E; Narjes F; Fossatelli M; Urbani A; Steinkühler C; De Francesco R; Pessi A
Anal Biochem; 1996 Aug; 240(1):60-7. PubMed ID: 8811880
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
[TBL] [Abstract][Full Text] [Related]
11. New continuous and specific fluorometric assays for Pseudomonas aeruginosa elastase and LasA protease.
Elston C; Wallach J; Saulnier J
Anal Biochem; 2007 Sep; 368(1):87-94. PubMed ID: 17553454
[TBL] [Abstract][Full Text] [Related]
12. A fluorescent protein-based biological screen of proteinase activity.
Huitema C; Eltis LD
J Biomol Screen; 2010 Feb; 15(2):224-9. PubMed ID: 20086215
[TBL] [Abstract][Full Text] [Related]
13. A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
Gratz A; Götz C; Jose J
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):234-9. PubMed ID: 19874207
[TBL] [Abstract][Full Text] [Related]
14. Active site properties of the 3C proteinase from hepatitis A virus (a hybrid cysteine/serine protease) probed by Raman spectroscopy.
Dinakarpandian D; Shenoy B; Pusztai-Carey M; Malcolm BA; Carey PR
Biochemistry; 1997 Apr; 36(16):4943-8. PubMed ID: 9125516
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase.
Davis GJ; Wang QM; Cox GA; Johnson RB; Wakulchik M; Dotson CA; Villarreal EC
Arch Biochem Biophys; 1997 Oct; 346(1):125-30. PubMed ID: 9328292
[TBL] [Abstract][Full Text] [Related]
16. From 10,000 to 1: Selective synthesis and enzymatic evaluation of fluorescence resonance energy transfer peptides as specific substrates for chymopapain.
Diaz-Mochon JJ; Planonth S; Bradley M
Anal Biochem; 2009 Jan; 384(1):101-5. PubMed ID: 18814838
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates.
Gouvea IE; Izidoro MA; Judice WA; Cezari MH; Caliendo G; Santagada V; dos Santos CN; Queiroz MH; Juliano MA; Young PR; Fairlie DP; Juliano L
Arch Biochem Biophys; 2007 Jan; 457(2):187-96. PubMed ID: 17184724
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.
Shang L; Zhang S; Yang X; Sun J; Li L; Cui Z; He Q; Guo Y; Sun Y; Yin Z
Antimicrob Agents Chemother; 2015 Apr; 59(4):1827-36. PubMed ID: 25421478
[TBL] [Abstract][Full Text] [Related]
19. The unusual catalytic triad of poliovirus protease 3C.
Sárkány Z; Polgár L
Biochemistry; 2003 Jan; 42(2):516-22. PubMed ID: 12525179
[TBL] [Abstract][Full Text] [Related]
20. Development of synthetic peptide substrates for the poliovirus 3C proteinase.
Weidner JR; Dunn BM
Arch Biochem Biophys; 1991 May; 286(2):402-8. PubMed ID: 1654789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
